Viewing Study NCT06548893



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06548893
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: None
First Post: 2024-08-08

Brief Title: Acceptance and Commitment Therapy ACT in Groups for Obsessive Compulsive Disorder A Clinical Trial in Brazil
Sponsor: None
Organization: None

Study Overview

Official Title: Group-based Acceptance and Commitment Therapy for Obsessive Compulsive Disorder A Clinical Trial
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if Acceptance and Commitment Therapy ACT Exposure and Response Prevention ERP in Group is effective to Obsessive Compulsive Disorder OCD in adults

Researchers will compare intervention to control group to see if those who attend the group therapy have better results than control group

Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig Twohig et al 2018

Participants will not have any medication adjustment during therapy
Participants will be assessed 3 times throughout the therapy plus an assessment in a 6-month follow-up
Detailed Description: The goal of this clinical trial is to learn if Acceptance and Commitment Therapy ACT Exposure and Response Prevention ERP in Group is effective to Obsessive Compulsive Disorder OCD in adults The main questions it aims to answer are

Can ACT in groups help decrease the severity of OCD symptoms
Can ACT in groups help increase psychological flexibility in this group
Can ACT in groups help increase quality of life in this group

Researchers will compare intervention n16 to control group n8 to see if those who attend the group therapy have better results than control group

We will perform an unequal randomization in a 21 ratio in blocks of 6 for allocation to each group The assessor of the outcomes of interest will be blinded to the group to which the participant was assigned

Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig Twohig et al 2018

Participants will not have any medication adjustment during therapy
Participants will be assessed 3 times throughout the therapy plus an assessment in a 6-month follow-up

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None